Results indicate that in vivo antibody-mediated tumor clearance appears to be dependent on binding to FcγRs by huIgG1 or huIgG1 LoF, whereas huIgG1σ which does not bind FcγR is unable to prevent tumor cell growth. Here, FCGR2A is linked to neoplasm.